Mark Sulkowski, MD
Johns Hopkins University · Johns Hopkins School of Medicine · Hepatitis Resource Network
Built from public records under this name as ClinicalTrials.gov spells it. A name can belong to more than one person, so each section says how its rows were tied to this name. No contact details are shown.
Trials
Studies that name Mark Sulkowski, MD as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-12 01:54 UTC. Open this list on ClinicalTrials.gov
- Ph2NCT04344600 · Peginterferon Lambda-1a for the Prevention and Treatment of SARS-CoV-2 (COVID-19) InfectionJohns Hopkins University · terminated · Sars-CoV-2 Infection · principal investigator
- N/ANCT03164902 · Digimeds to Optimize Adherence in Patients With Hepatitis C and Increased Risk for NonadherenceProteus Digital Health, Inc. · unknown · Hepatitis C, Chronic, Nonadherence, Patient · principal investigator
- N/ANCT02402218 · CHAMPS Study: Chronic HepAtitis C Management to ImProve OutcomeSJohns Hopkins University · completed · Hepatitis C Virus Infection, Response to Therapy of, Human Immunodeficiency Virus · principal investigator
- Ph1NCT01165359 · Evaluating the Safety of ITX 5061 in Treatment-Naive Hepatitis C (HCV)-Infected AdultsNational Institute of Allergy and Infectious Diseases (NIAID) · completed · Hepatitis C · study chair
- Ph3NCT00215891 · PEG-Interferon a-2b + Ribavirin for Treatment of Chronic HRN 005 Hepatitis C Infection in HIV-Infected Persons Not Previously Treated With InterferonHepatitis Resource Network · completed · Chronic Hepatitis C Infection in HIV-Infected Persons, HIV Infections · principal investigator
- Ph3NCT00215865 · PEG-Interferon a-2b + Ribavirin for Treatment of Patients With Chronic Hepatitis C Who Have Previously Failed to Achieve a Sustained Virologic Response Following Interferon Alfa or Interferon a-2b + Ribavirin TherapyHepatitis Resource Network · completed · Chronic Hepatitis C Virus Infection · principal investigator
Grants
NIH projects from RePORTER, fetched 2026-11-12 01:54 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. 1 other NIH projects list an investigator with the same name at a different institution and are left out. Coverage is US federal funding only; UK and EU funders are not searched yet.
No NIH project could be tied to this name by a shared trial or a matching institution.
NIH grants that fund their trials
These grant numbers are on the registry records of the trials above. They fund the trial, often through a cooperative group or network, and their principal investigator is usually someone else.
- HCV Disease Management in HIV-HCV Coinfected IDUsR01DA016065 · NIDA · JOHNS HOPKINS UNIVERSITY · PI Mark Sebastian Sulkowski · fiscal years 2003 to 2018Named on NCT02402218
Most cited trial papers
PubMed returned no clinical-trial papers for this author name.